Related Experiment Video
Updated: Jul 30, 2025

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer
Giacomo Nuvola1, Matteo Santoni2, Mimma Rizzo3
1Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italia.
Introduction:
The androgen/androgen receptor (AR) axis represents a key driver of treatment resistance in prostate cancer (PCa) patients receiving androgen deprivation therapy (ADT) and targeted agents, and a deeper comprehension of resistance mechanisms is fundamental to adopt effective therapeutic strategies.
Areas Covered:
We review the mechanisms of primary or secondary resistance to hormone therapy (HT) in PCa, especially focusing on available data and emerging evidence.
Expert Opinion:
First- and second-generation HT resistance has been associated with several AR-dependent and AR-independent mechanisms, ranging from the amplification of the AR gene locus to somatic AR mutations and the intratumoral synthesis of androgens from adrenal steroids and cholesterol. As reported in the current review, the development of novel and effective treatments is needed to personalize anticancer therapies in this setting and to finally improve clinical outcomes in patients with HT-resistant disease.
Insights
Understanding resistance to hormone therapy (HT) in prostate cancer (PCa) is crucial. This review details androgen receptor (AR) dependent and independent mechanisms driving treatment failure in PCa.
Area of Science:
- Oncology
- Molecular Biology
- Urology
Background:
- The androgen/androgen receptor (AR) axis is central to prostate cancer (PCa) progression and a primary cause of treatment resistance.
- Androgen deprivation therapy (ADT) and targeted agents are standard treatments, but resistance limits their efficacy.
Approach:
- This review synthesizes current data and emerging evidence on resistance mechanisms to hormone therapy (HT) in PCa.
- Focus is placed on both primary and secondary resistance pathways.
Key Points:
- Resistance mechanisms include AR gene amplification, somatic AR mutations, and intratumoral androgen synthesis.
- Both AR-dependent and AR-independent pathways contribute to treatment failure.
- Novel therapeutic strategies are required to overcome resistance.
Conclusions:
- A comprehensive understanding of resistance mechanisms is fundamental for developing effective therapeutic strategies.
- Personalized anticancer therapies are needed to improve outcomes for patients with HT-resistant PCa.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drug Therapy
Antianxiety Medications
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...